ICICI Bank (ICICIBANK)

FairStock Score: 52/100 — MIXED

Score breakdown: P/E: 2/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Investment Thesis

ICICI Bank is a high-quality private-sector lender with ROE near 16% and profit growth of ~16% YoY, but the stock is priced at 18.3x earnings and about 53% above its Graham number, leaving no fundamental margin of safety. Quant signals are mixed: an Ornstein-Uhlenbeck mean-reversion model is mildly bullish with a z-score of -1.28 and ~11-day half-life, but 5-day volume imbalance is strongly negative at -98.4% and earnings momentum is neutral. Net read: quality franchise, expensive stock, no institutional accumulation.

Rating: SELL (MEDIUM confidence) — 12M horizon

Strengths

• Healthy ROE of 16.07% and YoY profit growth of 15.95%
• Piotroski F-Score 7/9 and free cash flow of ₹54,311 Cr
• Excellent liquidity composite 98.6/100 with low market impact
• Large-cap private-sector bank with market cap around ₹10.2 lakh Cr
• Current ratio of 3.60 indicates short-term financial stability

Concerns

• No margin of safety: Graham number ₹881.59 vs current price around ₹1,417; discount roughly -53%
• DCF intrinsic value of ₹498.36 in existing analysis is far below market price
• ROCE of 7.87% is weak and scored 0/2 in FairStock model
• 5-day volume imbalance at -98.4% is a strong sell signal
• Low dividend yield of 0.85% and high PEG of about 3.23 from existing analysis

AI Analysis

Here is what you need to know about ICICI Bank. It is a large private-sector lender with a market cap near ₹10.2 lakh crore and a current price around ₹1,417. As a franchise, this is a quality bank: ROE is about 16 percent, profit growth is nearly 16 percent year-on-year, and the Piotroski F-Score is 7 out of 9. Free cash flow is roughly ₹54,311 crore, and liquidity is excellent. So the company is not broken. The issue is what you pay. The stock trades at about 18.3 times earnings while sales growth is only around 5 percent. The Graham number is ₹881.59, and a supplied DCF estimate is just ₹498.36—less than half the market price. That is why the FairStock score is only 2 out of 10 and the category is slow grower. Now let us talk quant. The Ornstein-Uhlenbeck mean-reversion model says the stock is mean-reverting with a z-score of minus 1.28 and a half-life around 11 days. That suggests a short-term bounce is possible, but it is a mild signal, not an extreme oversold reading. Volume tells a different story: the 5-day volume imbalance is minus 98.4 percent. That is a strong sell signal, meaning institutional buying is not showing up even though liquidity is strong and market impact is low. Earnings momentum is neutral, and the stock is down 2.13 percent over the last five days. Put it together: a good bank, but expensive, with weak accumulation and no margin of safety. My recommendation is to avoid fresh buying. If you already hold it, do so only as a long-term core position and understand the risk of a drawdown back toward value. I would not chase this stock here.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer